Eli Lilly (LLY) Financial Analysis & Valuation | Quarter Chart

Eli Lilly (LLY)

LLY
Price: $1185.08
Fair Value: 🔒
🔒score
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... more
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Ba... more
Description Shares
Market Cap$1.12TExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEODavid A. Ricks
IPO Date1972-06-01CAGR0.08%
Employees50,000Websitewww.lilly.com
Div. Yield0.65%Payout Ratio0.22%
Buy Back Yield0.56%Total Yield1.21%
LLY chart loading...
Fundamentals Technicals
Enterprise Value$973.91BP/E Ratio40.28
Forward P/E26.37PEG Ratio0.25
P/S Ratio15.42P/B Ratio33.94
P/CF Ratio51.67P/FCF Ratio82.07
EPS$29.42EPS Growth 1Y129.05%
EPS Growth 3Y359.97%EPS Growth 5Y342.61%
Revenue Growth 1Y47.44%Gross Margin0.84%
Operating Margin0.46%Profit Margin0.35%
ROE1.01%ROA0.22%
ROCE0.41%Current Ratio1.5
Quick Ratio1.1Cash Ratio0.14
Debt/Equity1.39Interest Coverage37.5
Altman Z Score9.9Piotroski Score6

View Eli Lilly financial charts →

Eli Lilly (LLY) valuation & financials

Eli Lilly (LLY) has a market capitalization of $1.12T and trades at a price-to-earnings ratio of 40.3. It operates in the Healthcare sector (Drug Manufacturers - General).

Eli Lilly's revenue grew +47.4% over the last year.

Eli Lilly's next earnings report is scheduled for August 5, 2026 before market open; analysts estimate EPS of $8.82.

📈 Analysts estimate LLY EPS of $8.82 for the upcoming quarter. See Eli Lilly revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Eli Lilly (LLY) — frequently asked questions

When does Eli Lilly (LLY) report earnings next?

Eli Lilly is expected to report earnings on August 5, 2026 before market open. Analysts estimate EPS of $8.82.

What is Eli Lilly's market cap?

Eli Lilly (LLY) has a market capitalization of $1.12T.

What is LLY's P/E ratio?

Eli Lilly trades at a price-to-earnings ratio of 40.3, with trailing twelve-month EPS of $29.42.

How fast is Eli Lilly growing?

Eli Lilly's revenue grew +47.4% over the last year.

Compare with other Healthcare companies: Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK) · Novartis (NVS)

Eli Lilly revenue & earnings charts →